GLP-1 Weight Loss
What Is Compounded Semaglutide? The 2026 Guide
What compounded semaglutide is, how it works, why it's legal, and how treatment through Toned works from online visit to delivery.
By Toned Team · Reviewed by the Toned editorial team
Published January 15, 2026 · Last reviewed July 7, 2026 · 4 min read
Compounded semaglutide is a prescription preparation of semaglutide made by a state-licensed 503A compounding pharmacy against an individual prescription. It is a separate product from the FDA-approved brand-name medications Ozempic and Wegovy — here is how they differ — and it typically costs a fraction of the brand-name price.
What Is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of medication that mimics a hormone your body naturally produces after eating. When you take semaglutide, it signals your brain that you're full, slows gastric emptying, and reduces appetite significantly.
Semaglutide is the molecule behind the brand-name medications Ozempic (approved for type 2 diabetes) and Wegovy (approved for chronic weight management). Compounded semaglutide is a separate, pharmacy-prepared product built around that same well-studied molecule — but it is not a brand-name medication, and the finished products are distinct.
What Does "Compounded" Mean?
Compounded medications are prepared by a licensed pharmacy, not manufactured by a pharmaceutical company like Novo Nordisk. They're made to order, typically when:
- A patient needs a dose or formulation that isn't commercially available
- A physician determines that a customized formulation better serves a patient's needs
Compounding pharmacies must comply with strict state and federal regulations. Pharmacies operating under Section 503A of the Federal Food, Drug, and Cosmetic Act prepare individualized medications for a specific patient against a valid prescription.
Is Compounded Semaglutide Legal?
Yes, under specific conditions. State-licensed compounding pharmacies operating under Section 503A may prepare individualized medications for a specific patient when a licensed provider writes a prescription for them. The regulatory specifics around GLP-1 compounding have shifted as FDA supply guidance has changed, which is why a licensed provider confirms an appropriate, compliant pharmacy source during your intake.
It's worth noting that compounded medications are not FDA-approved as finished drug products. The FDA approval process applies to specific drug products, not to pharmacies compounding medications under Section 503A.
How does treatment through Toned work?
Toned connects you with licensed telehealth providers and pharmacies. The process is straightforward:
- Online visit: You complete an online visit, and a licensed provider reviews your health history and goals
- Prescription if appropriate: If the provider determines treatment is right for you, they write a prescription
- Shipped to your door: Your medication is prepared and shipped from a licensed pharmacy
- Ongoing care: You check in with your provider and manage your treatment through a patient portal
Dosing and Titration
One of the biggest advantages of compounded semaglutide is dosing flexibility. Most patients start at 0.25 mg per week, administered as a subcutaneous injection. Over 4-8 weeks, doses are gradually increased based on tolerance and response, typically reaching 1 mg or 2.4 mg at maintenance.
Your provider guides every step of this titration based on how you're responding and any side effects you experience, with check-ins handled through the patient portal.
What should you expect month by month?
Most patients notice a meaningful reduction in appetite within the first two weeks. Weight loss typically begins in weeks two through four, and becomes more pronounced by months two and three.
Clinical data shows that patients using semaglutide for weight management lose an average of 15-20% of body weight over 68 weeks when combined with lifestyle support and ongoing clinical care.
The Bottom Line
Compounded semaglutide gives more people access to a well-studied weight loss intervention at a more accessible price point. Sourced from a licensed 503A pharmacy and prescribed by a qualified provider after an individual evaluation, it is a widely prescribed option for chronic weight management.
If you're ready to find out whether you're a candidate, the first step is a simple online visit. Learn more about how it works.
References
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021. PubMed
- U.S. FDA. Compounding and the FDA: Questions and Answers. FDA.gov
- Ghusn W et al. Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Netw Open. 2022. PubMed
- Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021. PubMed
This article is for general education and is not medical advice. Talk to a licensed provider about your individual situation.